Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma

Falchi, L., Hutchings, M., Carlo-Stella, C., Morschhauser, F., Dickinson, M., Cartron, G., … Bachy, E. (2025, April 1). Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma. Haematologica. Ferrata Storti Foundation. https://doi.org/10.3324/haematol.2024.286257